TRACON Pharmaceuticals Inc. (TCON) Dipped -5.03% or -0.08 To Price $1.51 On Friday


TRACON Pharmaceuticals Inc. (TCON) dipped -5.03% or -0.08 to $1.51. It is nearly 217755 shares traded, which is 241.92% compare to the average total volume 90013. The market cap of TCON is $45.06 million. The year to date change is -59.6%. The 52 week price range is from $1.49 to $3.6. Price of TCON have changed -11.67% during last week. It have changed -29.33% over last month, -40.00% over last 3 months, -44.21% over last 6 months and -45.17% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TCON is 2.05. It is 35.76% above current price. The 200-day Moving Averages for TCON is 2.51. It is 66.23% above current price. The 52-week High is 3.6. It is 138.41% from the current price. The 52-week Low is 1.49. It is -1.32% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of TCON is 2.21 on 2018-09-28. Short % to float is 0.65%. There are some statistics of TCON. It is has market cap $45.06 million. The share outstanding is 29.84 million. The average volume is 90013. The revenue is 7.50M. It has 35.86M cash and 7.32M in debt. The percent of top 15 Institution holding is 69.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TCON is -86.04%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TCON is -53.09%.


Tags:

Share this post